1. Adam EK, Doane LD, Zinbarg RE, Mineka S, Craske MG, Griffith JW. Prospective prediction of major depressive disorder from cortisol awakening responses in adolescence. Psychoneuroendocrinology 2010; 35: 921-31.
2.
Anacker C, Zunszain PA, Carvalho LA, Pariante CM. The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology 2011; 36: 415-25.
3.
Andrade C. The P value and statistical significance: misunderstandings, explanations, challenges, and alternatives. Indian J Psychol Med 2019; 41: 210-215.
4.
Bains N, Abdijadid S. Major Depressive Disorder. Stat Pearls Publishing, Florida 2023.
5.
Barili F, Parolari A, Kappetein PA, Freemantle N. Statistical primer: heterogeneity, random- or fixed-effects model analyses? Interact Cardiovasc Thorac Surg 2018; 27: 317-321.
6.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
7.
Bertollo AG, Grolli RE, Plissari ME, Gasparin VA, Quevedo J, Réus GZ, Bagatini MD, Ignácio ZM. Stress and serum cortisol levels in major depressive disorder: a cross-sectional study. AIMS Neurosci 2020; 7: 459-469.
8.
Brown D. A review of the PubMed PICO tool: using evidence-based practice in health education. Health Promot Pract 2020; 21: 496-498.
9.
Damjanovic SS, Stojic RV, Lalic NM, Jotic AZ, Macut DP, Ognjanovic SI, Petakov MS, Popovic BM. Relationship between basal metabolic rate and cortisol secretion throughout pregnancy. Endocrine 2009; 35: 262-268.
10.
Dettori JR, Norvell DC, Chapman JR. Seeing the forest by looking at the trees: how to interpret a meta-analysis forest plot. Global Spine J 2021; 11: 614-616.
11.
Dienes KA, Hazel NA, Hammen CL. Cortisol secretion in depressed, and at-risk adults. Psychoneuroendocrinology 2013; 38: 927-940.
12.
Direk N, Dekker MJ, Luik AI, Kirschbaum C, de Rijke YB, Hofman A, Hoogendijk WJ, Tiemeier H. The very low-dose dexamethasone suppression test in the general population: a cross-sectional study. PLoS One 2016; 11: e0164348.
13.
Dziurkowska E, Wesolowski M. Cortisol as a biomarker of mental disorder severity. J Clin Med 2021; 10: 5204.
14.
Elovic A, Pourmand A. MDCalc medical calculator app review. J Digit Imaging 2019; 32: 682-684.
15.
Fujiwara T, Cherrington AD, Neal DN, McGuinness OP. Role of cortisol in the metabolic response to stress hormone infusion in the conscious dog. Metabolism 1996; 45: 571-578.
16.
George BJ, Aban IB. An application of meta-analysis based on DerSimonian and Laird method. J Nucl Cardiol 2016; 23: 690-692.
17.
Ghaziuddin N, King CA, Welch KB, Zaccagnini J, WeidmerMikhail E, Mellow AM, Ghaziuddin M, Greden JF. Serotonin dysregulation in adolescents with major depression: hormone response to meta-chlorophenylpiperazine (mCPP) infusion. Psychiatry Res 2000; 95: 183-194.
18.
Grant R, Bilgin A, Guest J, Morris M, Garg M, Pearce R. The relative value of measures of omega-3 index, perceived stress, cortisol and sleep time in identifying depression among a cohort of Australian adolescents. Int J Child Health Nutr 2015: 4: 40-49.
19.
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928.
20.
Hirtz R, Libuda L, Hinney A, Föcker M, Bühlmeier J, Antel J, Holterhus PM, Kulle A, Kiewert C, Hebebrand J, Grasemann C. Lack of evidence for a relationship between the hypothalamus-pituitary-adrenal and the hypothalamus-pituitary-thyroid axis in adolescent depression. Front Endocrinol (Lausanne) 2021; 12: 1662243.
21.
Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 2006; 11: 193-206.
22.
Iob E, Kirschbaum C, Steptoe A. Persistent depressive symptoms, HPA-axis hyperactivity, and inflammation: the role of cognitive-affective and somatic symptoms. Mol Psychiatry 2020; 25: 1130-1140.
23.
Kaestner F, Hettich M, Peters M, Sibrowski W, Hetzel G, Ponath G, Arolt V, Cassens U, Rothermundt M. Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. J Affect Disord 2005; 87: 305-311.
24.
Keller J, Gomez R, Williams G, Lembke A, Lazzeroni L, Murphy GM Jr, Schatzberg AF. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Mol Psychiatry 2017; 22: 527-536.
25.
Kennedy SH. Core symptoms of major depressive disorder: relevance to diagnosis and treatment. Dialogues Clin Neurosci 2008; 10: 271-277.
26.
Klimes-Dougan B, Eberly LE, Westlund Schreiner M, Kurkiewicz P, Houri A, Schlesinger A, Thomas KM, Mueller BA, Lim KO, Cullen KR. Multilevel assessment of the neurobiological threat system in depressed adolescents: interplay between the limbic system and hypothalamic-pituitary-adrenal axis. Dev Psychopathol 2014; 26: 1321-1335.
27.
Lam JCW, Shields GS, Trainor BC, Slavich GM, Yonelinas AP. Greater lifetime stress exposure predicts blunted cortisol but heightened DHEA responses to acute stress. Stress Health 2019; 35: 15-26.
28.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700.
29.
Maughan B, Collishaw S, Stringaris A. Depression in childhood and adolescence. J Can Acad Child Adolesc Psychiatry 2013; 22: 35-40.
30.
Mikulska J, Juszczyk G, Gawrońska-Grzywacz M, Herbet M. HPA Axis in the pathomechanism of depression and schizophrenia: new therapeutic strategies based on its participation. Brain Sci 2021; 11: 1298.
31.
Ming Q, Zhong X, Zhang X, Pu W, Dong D, Jiang Y, Gao Y, Wang X, Detre JA, Yao S, Rao H. State-independent and dependent neural responses to psychosocial stress in current and remitted depression. Am J Psychiatry 2017; 174: 971-979.
32.
Morris MC, Kouros CD, Mielock AS, Rao U. Depressive symptom composites associated with cortisol stress reactivity in adolescents. J Affect Disord 2017; 210: 181-188.
33.
Morris MC, Rao U. Cortisol response to psychosocial stress during a depressive episode and remission. Stress 2014; 17: 51-58.
34.
Nandam LS, Brazel M, Zhou M, Jhaveri DJ. Cortisol and major depressive disorder-translating findings from humans to animal models and back. Front Psychiatry 2020; 10: 974.
35.
Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, Mohr DC, Schatzberg AF. Major depressive disorder. Nat Rev Dis Primers 2016; 2: 16065.
36.
Rao U, Hammen C, Ortiz LR, Chen LA, Poland RE. Effects of early and recent adverse experiences on adrenal response to psychosocial stress in depressed adolescents. Biol Psychiatry 2008; 64: 521-526.
37.
Rao U, Poland RE. Electroencephalographic sleep and hypothalamic-pituitary-adrenal changes from episode to recovery in depressed adolescents. J Child Adolesc Psychopharmacol 2008; 18: 607-613.
38.
Ross LE, Grigoriadis S, Mamisashvili L, Koren G, Steiner M, Dennis CL, Cheung A, Mousmanis P. Quality assessment of observational studies in psychiatry: an example from perinatal psychiatric research. Int J Methods Psychiatr Res 2011; 20: 224-234.
39.
Schmidt L, Shokraneh F, Steinhausen K, Adams CE. Introducing RAPTOR: RevMan parsing tool for reviewers. Syst Rev 2019; 8: 151.
40.
Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg 2018; 126: 1763-1768.
41.
Seematter G, Binnert C, Tappy L. Stress and metabolism. Metab Syndr Relat Disord 2005; 3: 8-13.
42.
Shadrina M, Bondarenko EA, Slominsky PA. Genetics factors in major depression disease. Front Psychiatry 2018; 9: 334.
43.
Singh JA, Siddiqi M, Parameshwar P, Chandra-Mouli V. World Health Organization guidance on ethical considerations in planning and reviewing research studies on sexual and reproductive health in adolescents. J Adolesc Health 2019; 64: 427-429.
44.
Spanemberg L, Caldieraro MA, Vares EA, Wollenhaupt-Aguiar B, Kauer-Sant’Anna M, Kawamoto SY, Galvão E, Parker G, Fleck MP. Biological differences between melancholic and nonmelancholic depression subtyped by the CORE measure. Neuropsychiatr Dis Treat 2014; 10: 1523-1531.
45.
Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 2001; 54: 1046-1055.
46.
Tonon AC, Carissimi A, Schimitt RL, de Lima LS, Pereira FDS, Hidalgo MP. How do stress, sleep quality, and chronotype associate with clinically significant depressive symptoms? A study of young male military recruits in compulsory service. Braz J Psychiatry 2020; 42: 54-62.
47.
Ulrike S, Reinhold L, Dirk H. Major depression in young girls is related to altered cortisol awakening response. Eur Child Adolesc Psychiatry 2013; 22: 379-384.
48.
Varghese FP, Brown ES. The hypothalamic-pituitary-adrenal axis in major depressive disorder: a brief primer for primary care physicians. Prim Care Companion J Clin Psychiatry 2001; 3: 151-155.
49.
Vrshek-Schallhorn S, Doane LD, Mineka S, Zinbarg RE, Craske MG, Adam EK. The cortisol awakening response predicts major depression: predictive stability over a 4-year follow-up and effect of depression history. Psychol Med 2013; 43: 483-493.
50.
Zimmermann KS, Richardson R, Baker KD. Developmental changes in functional connectivity between the prefrontal cortex and amygdala following fear extinction. Neurobiol Learn Mem 2023; 205: 107847.
